Nanocarrier vaccines for SARS-CoV-2

The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death associated with substantive social, economic and societal impacts. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative t...

Descripción completa

Detalles Bibliográficos
Autores principales: Machhi, Jatin, Shahjin, Farah, Das, Srijanee, Patel, Milankumar, Abdelmoaty, Mai Mohamed, Cohen, Jacob D., Singh, Preet Amol, Baldi, Ashish, Bajwa, Neha, Kumar, Raj, Vora, Lalit K., Patel, Tapan A., Oleynikov, Maxim D., Soni, Dhruvkumar, Yeapuri, Pravin, Mukadam, Insiya, Chakraborty, Rajashree, Saksena, Caroline G., Herskovitz, Jonathan, Hasan, Mahmudul, Oupicky, David, Das, Suvarthi, Donnelly, Ryan F., Hettie, Kenneth S., Chang, Linda, Gendelman, Howard E., Kevadiya, Bhavesh D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794055/
https://www.ncbi.nlm.nih.gov/pubmed/33428995
http://dx.doi.org/10.1016/j.addr.2021.01.002

Ejemplares similares

Ejemplares similares